Treatment of neurolept-induced tardive dyskinesia

被引:39
|
作者
Jankelowitz, Stacey K. [1 ]
机构
[1] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia
来源
NEUROPSYCHIATRIC DISEASE AND TREATMENT | 2013年 / 9卷
关键词
tardive dyskinesia; treatment; neuroleptic agents; PLACEBO-CONTROLLED TRIAL; DEEP BRAIN-STIMULATION; SCHIZOPHRENIA SPECTRUM DISORDERS; HYPERKINETIC MOVEMENT-DISORDERS; GENETIC ASSOCIATION ANALYSIS; VITAMIN-E TREATMENT; OPEN-LABEL TRIAL; 1A2; CYP1A2; GENE; DOUBLE-BLIND; RECEPTOR GENE;
D O I
10.2147/NDT.S30767
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tardive dyskinesia (TDK) includes orobuccolingual movements and "piano-playing" movements of the limbs. It is a movement disorder of delayed onset that can occur in the setting of neuroleptic treatment as well as in other diseases and following treatment with other drugs. The specific pathophysiology resulting in TDK is still not completely understood but possible mechanisms include postsynaptic dopamine receptor hypersensitivity, abnormalities of striatal gamma-aminobutyric acid (GABA) neurons, and degeneration of striatal cholinergic interneurons. More recently, the theory of synaptic plasticity has been proposed. Considering these proposed mechanisms of disease, therapeutic interventions have attempted to manipulate dopamine, GABA, acetylcholine, norepinephrine and serotonin pathways and receptors. The data for the effectiveness of each class of drugs and the side effects were considered in turn.
引用
收藏
页码:1371 / 1380
页数:10
相关论文
共 50 条
  • [1] Current treatment of tardive dyskinesia
    Margolius, Adam
    Fernandez, Hubert H.
    PARKINSONISM & RELATED DISORDERS, 2019, 59 : 155 - 160
  • [2] Treatment of Tardive Dyskinesia
    Bashir, Hassaan H.
    Jankovic, Joseph
    NEUROLOGIC CLINICS, 2020, 38 (02) : 379 - +
  • [3] Pathophysiology, prognosis and treatment of tardive dyskinesia
    Takeuchi, Hiroyoshi
    Mori, Yasuhiro
    Tsutsumi, Yuichiro
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2022, 12
  • [4] Valbenazine for the Treatment of Adults with Tardive Dyskinesia
    Gupta, Harshit
    Moity, Alycee R.
    Jumonville, Allison
    Kaufman, Sarah
    Edinoff, Amber N.
    Kaye, Alan D.
    HEALTH PSYCHOLOGY RESEARCH, 2021, 9 (01):
  • [5] Prevention and Treatment of Antipsychotic-induced Tardive Dyskinesia
    Erbe, Sebastian
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2019, 87 (04) : 217 - 224
  • [6] Valbenazine for the treatment of tardive dyskinesia
    Mueller, Thomas
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (12) : 1135 - 1144
  • [7] Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia
    Vijayakumar, Dhanya
    Jankovic, Joseph
    DRUGS, 2016, 76 (07) : 779 - 787
  • [8] Motor Symptoms of Schizophrenia: Is Tardive Dyskinesia a Symptom or Side Effect? A Modern Treatment
    Lerner, Vladimir
    Miodownik, Chanoch
    CURRENT PSYCHIATRY REPORTS, 2011, 13 (04) : 295 - 304
  • [9] Tardive Dyskinesia: Treatment Update
    Arya, Divya
    Khan, Tarannum
    Margolius, Adam J.
    Fernandez, Hubert H.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2019, 19 (09)
  • [10] Treatment Recommendations for Tardive Dyskinesia
    Ricciardi, Lucia
    Pringsheim, Tamara
    Barnes, Thomas R. E.
    Martino, Davide
    Gardner, David
    Remington, Gary
    Addington, Donald
    Morgante, Francesca
    Poole, Norman
    Carson, Alan
    Edwards, Mark
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2019, 64 (06): : 388 - 399